Cancer tissue sample problems remain, inquiry told
16.07.2008 12:01
Health
- Source: cbc.ca
Newfoundland and Labrador's largest pathology laboratory had problems with its breast cancer testing program as recently as this spring, an inquiry has been told. Les Simms, who retired in May as a lab technologist with Eastern Health, told the Cameron inquiry Tuesday that the lab was still dealing with quality problems when his career came to a close. "It had improved but it still wasn't up to where we wanted it," Simms told Justice Margaret Cameron, who is investigating what went wrong with hormone receptor testing between 1997 and 2005. The inquiry has often been told that Eastern Health has cleaned up the pathology lab since it identified serious problems with breast cancer testing three years ago. Simms agreed that things have improved, but there were still serious problems earlier this year with how the source samples are prepared. "They tried various things, but they're still getting suboptimal tissue, whether it's from the fixation or not acquiring a proper technique for a proper piece of tissue or tissue too big or too thick," Simms testified. Fixation, the process of halting the deterioration of cells on a lab slide, has frequently been cited as a key problem at the St. John's lab. Largely self-taught during careerSimms told the inquiry he had been given no formal instruction on testing for estrogen receptors and progesterone receptors. More than 300 breast cancer patients had received inaccurate ER/PR results, with most erroneously disqualified for treatment with the powerful antihormonal therapy Tamoxifen. Simms also said that during his three-decade career, much of what he learned was self-taught. He told the inquiry that now-retired pathologist Gershon Ejeckam — who flagged serious problems with the lab in 2003 — had attempted to teach lab technologists about the complexities of testing procedures, but the sessions did not prove fruitful. "You know, teaching us — it was a great idea," he said. "But Dr. Ejeckam and Dr. [breast cancer pathologist Beverley] Carter tended to disagree on what they were looking at … They would have disagreements, so it came to the point [where] we're saying, 'This is pointless, all right. If you're telling me this is this, and Dr. Carter is there questioning it, well, how am I supposed to learn or whose word am I supposed to take?' " he said. "That was for a very short period of time. It was a great idea. It just didn't work." Technologist gives list of possible testing problemsAlso Tuesday, technologist Ken Green, who testified last week, returned to the stand. He presented a list of possible factors that could explain how hundreds of ER/PR test results produced in St. John's over an eight-year period turned out to be wrong. Green said such possible factors included fixation as well as "handling of the surgical specimen from the OR [operating room] before it reaches the lab." Echoing advice presented to the inquiry by Ejeckam and others, Green said the lab needs technologists who are dedicated to the complex immunohistochemical staining process, with "dedicated pathologists to oversee it." External reviews found lab technologists were responsible for many areas and could not specialize in a changing field. Green recommended that technologists be offered continuing education so they can keep up to date with changing technologies and methodology. Cameron has been hearing evidence since March on what went wrong at the St. John's pathology lab, and about how officials reacted in 2005 when they learned of testing problems. Story Tools: E-MAIL | PRINT | Text Size: SMLXL | REPORT TYPO | SEND YOUR FEEDBACKRelatedInternal LinksBreast cancer database has weaknesses: advocatePathologists press for national testing standardsLab technologist praises pathologist at cancer inquiryInquiryARCHIVE: Read previous coverage of the Cameron inquiryIN DEPTH: Misdiagnosed: Anatomy of Newfoundland's cancer-testing scandalIN DEPTH: Hormone receptor testingHealth HeadlinesHuntington's trigger found, could help with treatmentNew research appears to show that Huntington's disease is caused by an overactive immune response that occurs in the bloodstream and in the brain.Cancer tissue sample problems remain, inquiry toldNewfoundland and Labrador's largest pathology laboratory had problems with its breast cancer testing program as recently as this spring, an inquiry has been told.Study shakes up belief that low-salt diet helps asthmaThe long-standing advice that asthmatics adhere to a low-sodium diet to improve their symptoms has been challenged by a new study.Global warming could cause rise in kidney stones: studyResearchers at the University of Texas believe cases of kidney stones could increase by as much as 30 per cent in some regions of the United States by 2050 if predicted temperature increases play out. Direct drug ad ban a 'stupid quagmire': CMAJ editorHealth Canada's uneven enforcement of its ban on direct-to-consumer drug advertising may strengthen the hand of companies fighting to have it overturned, the Canadian Medical Association Journal said. Health FeaturesBIRTH CONTROLThird World woesMillions need help, advocates sayIN DEPTHRed, red wineHealth pros and consHEALTHLife spanLongevity secrets from around the worldBlogSherraine SchalmI am fencer, hear me roar!HEALTH & FITNESSPeter HadzipetrosBreaking up's not that hard to doPeople who read this also read …
| 
Add comment